2018-11-01T09:57:08-05:00 2017-12-31 951777440 GREEN HASSON & JANKS LLP 10990 WILSHIRE BLVD 16TH FLOOR LOS ANGELES CA 900243929 990 2017-01-01 261636099 MELANOMA RESEARCH ALLIANCE FOUNDATION MELA 2023368935 1101 NEW YORK AVE NW NO 620 WASHINGTON DC 20005 MICHAEL KAPLAN PRESIDENT/CEO 2023368935 2018-10-31 1 LIZBETH G NEVAREZ P01399868 3108731600 38.186.35.254 2018-10-31 13:31:18 PD P DA39A3EE5E6B4B0D3255BFEF95601890AFD80709 6A5B9BBBC0C15FAE84D58941C3D029285B6C5672 2017 2018-06-14 16:35:46Z MICHAEL KAPLAN 1101 NEW YORK AVE NW NO 620 WASHINGTON DC 20005 35206831 0 X WWW.MELANOMARESEARCHALLIANCE.ORG X 2007 DE TO ACCELERATE SCIENTIFIC DISCOVERY TO ELIMINATE SUFFERING AND DEATH DUE TO MELANOMA 22 20 10 50 0 0 8445094 24404447 0 0 66405 173572 -181548 -57222 8329951 24520797 20602554 9161167 0 0 1009088 1412639 0 0 646447 988893 1173152 22600535 11746958 -14270584 12773839 30882453 42426052 13389135 12059569 17493318 30366483 TO END SUFFERING AND DEATH DUE TO MELANOMA BY COLLABORATING WITH ALL STAKEHOLDERS TO ACCELERATE POWERFUL RESEARCH, ADVANCE CURES FOR ALL PATIENTS, AND PREVENT MORE MELANOMAS. 0 0 10790216 9161167 THE MELANOMA RESEARCH ALLIANCE FOUNDATION ("MRA") SUPPORTS AMBITIOUS AND INNOVATIVE PROJECTS, INITIATED BY INDIVIDUAL SCIENTISTS AND SCIENCE RESEARCH TEAMS, TO PREVENT, DETECT AND TREAT MELANOMA. MRA CONVENES A WORLD CLASS, CROSS-DISCIPLINARY GROUP OF EXPERT RESEARCHERS POSSESSING CLINICAL AND SCIENTIFIC EXPERTISE TO DEVELOP A RESEARCH AGENDA THAT WILL PROVIDE INNOVATIVE SOLUTIONS TO CRITICAL RESEARCH ISSUES LEADING TO BETTER TREATMENTS AND A CURE FOR MELANOMA. MRA MAKES GRANTS TO DOMESTIC AND FOREIGN RESEARCH UNIVERSITIES, MEDICAL SCHOOLS, AND NONPROFIT MEDICAL RESEARCH ORGANIZATIONS DIRECTLY INVOLVED IN DETERMINING THE CAUSES AND CURES OF MELANOMA ON THE CONDITION THAT SUCH RESEARCH BE MADE AVAILABLE TO THE SCIENTIFIC COMMUNITY. 10790216 1 1 0 1 0 0 0 0 0 0 1 0 0 0 1 0 1 1 0 0 1 1 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 1 X 18 0 1 10 1 0 0 0 0 0 1 1 0 0 0 0 X 22 20 1 0 0 0 0 0 0 1 0 0 0 1 1 1 1 1 1 1 0 0 AL AK AR CA CO CT DC FL GA HI IL KS KY ME MD MA MI MN MO NV NH NJ NM NY NC ND OH OK OR PA RI SC TN UT VA WA WV WI X X MICHAEL KAPLAN 2023368935 1101 NEW YORK AVE NW 620 WASHINGTON DC 20005 DEBRA BLACK CHAIR/CO-FOUNDER 10.00 0.00 X X 0 0 0 MARGARET ANDERSON DIRECTOR/SECRETARY (LEFT MID-2017) 5.00 40.00 X X 0 235117 16395 LEON BLACK DIRECTOR/CO-FOUNDER 0.30 0.00 X 0 0 0 MARIA BELL DIRECTOR 0.30 0.00 X 0 0 0 ELLEN DAVIS DIRECTOR 0.30 0.00 X 0 0 0 JASON FEDERICI DIRECTOR 0.30 0.00 X 0 0 0 JAMI GERTZ DIRECTOR 0.30 0.00 X 0 0 0 DAISY HELMAN DIRECTOR 0.30 0.00 X 0 0 0 SUSAN HESS DIRECTOR 0.30 0.00 X 0 0 0 MICHAEL KLOWDEN DIRECTOR 5.30 40.00 X 0 622791 32346 AMANDA ELLIAN DIRECTOR 0.30 0.00 X 0 0 0 NANCY MARKS DIRECTOR 0.30 0.00 X 0 0 0 MICHAEL MILKEN DIRECTOR 0.30 15.00 X 0 0 0 RICHARD RESSLER DIRECTOR 0.30 0.00 X 0 0 0 MARY JO ROGERS DIRECTOR 0.30 0.00 X 0 0 0 JEFFREY ROWBOTTOM DIRECTOR 0.30 0.00 X 0 0 0 ELLIOTT SIGAL DIRECTOR 0.30 0.00 X 0 0 0 GREGORY SIMON DIRECTOR 0.30 0.00 X 0 0 0 JONATHAN SIMONS DIRECTOR 0.30 0.00 X 0 0 0 JONATHAN SOKOLOFF DIRECTOR 0.30 0.00 X 0 0 0 ELIZABETH STANTON DIRECTOR 0.30 0.00 X 0 0 0 SUZANNE TOPALIAN DIRECTOR 5.00 0.00 X 0 0 0 MICHAEL KAPLAN PRESIDENT & CEO 40.00 0.00 X 301504 0 16128 KAMYAB HASHEMI-NEJAD TREASURER 10.00 40.00 X 0 187047 25283 LOUISE PERKINS CHIEF SCIENCE OFFICER 40.00 0.00 X 292163 0 29901 KRISTEN MUELLER SCIENTIFIC PROGRAM DIRECTOR 40.00 0.00 X 132417 0 930 JOAN RUSSO FROM 717 CHIEF DEVELOPMENT OFFICER 40.00 0.00 X 103578 0 200 829662 1044955 121183 4 0 1 0 0 20910402 3494045 520005 24404447 160799 160799 10422085 10409312 12773 12773 12773 198400 20910402 276722 -78322 -78322 MISCELLANEOUS REVENUE 900099 21100 21100 21100 24520797 0 0 116350 7365181 7365181 1795986 1795986 317632 190579 47645 79408 922418 590168 101645 230605 20499 13049 2325 5125 81605 51760 9444 20401 70485 44406 8458 17621 21900 21900 8384 5282 1006 2096 225160 155648 7747 61765 78480 49442 9418 19620 135688 85483 16283 33922 138887 87499 16666 34722 301810 190140 36217 75453 8026 5056 963 2007 15732 9911 1888 3933 EVENTS PRODUCTION 206989 130403 24839 51747 DUE AND SUBSCRIPTION 14210 8952 1705 3553 STATE FILING FEES 11825 7450 1419 2956 RESEARCH MATERIALS 5000 3150 600 1250 1061 671 127 263 11746958 10790216 310295 646447 2536559 6718915 20019195 13428469 8288256 18009454 33604 75043 101179 101179 3579 0 4194171 1260 0 30882453 42426052 74168 137004 13204967 11848581 110000 57240 0 16744 13389135 12059569 X 9205062 12357029 8288256 18009454 17493318 30366483 30882453 42426052 X 12773839 117750 -18424 X 0 1 X 1 0 X X X 1 THE MILKEN INSTITUTE 954240775 7 1 9079591 0 1 9079591 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 PART IV, SECTION A, LINE 6 THE AMOUNT OF SUPPORT REPORTED TO MILKEN INSTITUTE REPRESENTS THE AMOUNT OF FUNDS THAT MRA PAYS DIRECTLY TO RESEARCH ORGANIZATIONS LISTED ON SCHEDULES F AND I THAT SUPPORT MELANOMA RESEARCH THAT ADVANCES THE MISSION OF BOTH MRA AND THE MILKEN INSTITUTE. MRA PROVIDES DIRECT SUPPORT TO PUBLIC CHARITIES AND EDUCATIONAL INSTITUTIONS FOR THE PURPOSES OF CANCER RESEARCH SPECIFICALLY RELATED TO MELANOMA. SUPPORTING THESE UNRELATED RESEARCH ORGANIZATIONS DIRECTLY SUPPORTS THE MISSION OF THE MILKEN INSTITUTE SINCE PART OF THE INSTITUTE'S MISSION IS TO IMPROVE HEALTH WORLDWIDE. BY MRA PROVIDING THE GRANTS DIRECTLY TO THE CHARITIES AND EDUCATIONAL INSTITUTIONS, IT FURTHER ASSISTS THE MILKEN INSTITUTE. BECAUSE THERE IS A DIRECT LINE OF COMMUNICATION BETWEEN DONOR AND GRANT RECIPIENT, THE INSTITUTE CAN RELY ON MRA TO PROVIDE GRANT MONITORING AND GRANT SUPPORT SERVICES TO GRANT RECIPIENTS. 2000 2000 11098511 11100511 705026 176257 0 0 738010 649781 1000000 705026 3092817 4639226 18000 1000 1500 2000 22500 184503 162445 250000 176257 773205 1159808 101179 101179 0 0 DUE TO AFFILIATE 16744 16744 24582963 117750 44416 -100000 62166 24520797 0 24520797 11709798 44416 -81576 -37160 11746958 0 11746958 PART XI, LINE 2D - OTHER ADJUSTMENTS: LOSS ON WRITE-OFF OF UNCOLLECTIBLE PLEDGES RECEIVABLE -100,000. PART XII, LINE 2D - OTHER ADJUSTMENTS: DISCOUNT ON GRANTS -137,515. GRANT FUNDS RETURNED 55,939. 1 MIDDLE EAST AND NORTH AFRICA 0 0 GRANTS TO RECIPIENTS LOCATED IN THE REGION 750000 EAST ASIA AND THE PACIFIC 0 0 GRANTS TO RECIPIENTS LOCATED IN THE REGION 324991 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 GRANTS TO RECIPIENTS LOCATED IN THE REGION 720995 0 0 0 0 0 0 1795986 0 1795986 MIDDLE EAST AND NORTH AFRICA - ALGERIA, BAHRAIN, DJIBOUTI, EGYPT, ESTABLISHED INVESTIGATOR AWARD 375000 WIRE MIDDLE EAST AND NORTH AFRICA - ALGERIA, BAHRAIN, DJIBOUTI, EGYPT, ESTABLISHED INVESTIGATOR AWARD 375000 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM ESTABLISHED INVESTIGATOR AWARD 302400 WIRE EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, ESTABLISHED INVESTIGATOR AWARD 224991 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM YOUNG INVESTIGATOR AWARD 218595 WIRE EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, PILOT AWARD 100000 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM PILOT AWARD 100000 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) PILOT AWARD 100000 8 0 0 0 0 0 0 PART I, LINE 2: EACH PROPOSAL TO THE MRA IS REVIEWED FOR SCIENTIFIC MERIT AND TRANSLATIONAL AND CLINICAL IMPACT BY MRA'S WORLD-CLASS GRANT REVIEW COMMITTEE (GRC). CRITERIA ARE DESCRIBED IN THE MRA'S REQUEST FOR PROPOSALS. GRC MEMBERS ARE SENIOR THOUGHT-LEADERS IN MELANOMA AND CANCER RESEARCH. AFTER SCIENTIFIC PEER REVIEW BY THE GRC, THE MRA BOARD OF DIRECTORS APPROVES FINAL RESEARCH AWARDS FOR FUNDING. RESEARCH AWARD FUNDS ARE DISPENSED ON AN ANNUAL BASIS, CONTINGENT UPON MRA STAFF REVIEW OF ANNUAL PROGRESS REPORTS SUBMITTED BY THE GRANTEES. PART I, LINE 3: AWARDEES PROVIDE MRA WITH ANNUAL WRITTEN REPORTS OF THEIR RESEARCH PROGRESS AND COMPLIANCE WITH BUDGET GUIDELINES. FUNDS ARE DISTRIBUTED IN ANNUAL INSTALLMENTS AND NEXT YEAR'S INSTALLMENT IS NOT PROVIDED UNTIL SATISFACTORY REVIEW BY THE MRA CHIEF SCIENCE OFFICER AND SCIENTIFIC PROGRAM DIRECTOR. AWARDEES MUST KEEP SYSTEMATIC AND COMPLETE RECORDS ON THE RECEIPT AND DISBURSEMENT OF ALL AWARD FUNDS, AND MAY NOT COMMINGLE ANY FUNDS FROM OTHER SOURCES. SOTHEBY'S 10 YEAR GALA 19243964 19184964 59000 69434 34725 LEVEREDGED FINANCE 1864838 1725438 139400 2570 129150 40843 21108802 20910402 198400 72004 129150 75568 276722 -78322 1 THE REGENTS OF UCLA 10889 WILSHIRE BOULEVARD LOS ANGELES CA 90095 956006143 PUBLIC UNIVERSITY 1100000 ACADEMIC-INDUSTRY PARTNERSHIP AWARD, YOUNG INVESTIGATOR AWARDS JOHNS HOPKINS UNIVERSITY 3910 KESWICK ROAD N4327-B BALTIMORE MD 21211 520595110 501 (C) (3) 750000 ESTABLISHED INVESTIGATOR AWARDS BRIGHAM & WOMEN'S HOSPITAL 75 FRANCIS STREET BOSTON MA 02115 042312909 501 (C) (3) 600000 ESTABLISHED INVESTIGATOR AWARD, YOUNG INVESTIGATOR AWARD DANA FARBER CANCER INSTITUTE 450 BROOKLINE AVE BP418 BOSTON MA 02215 042263040 501 (C) (3) 600000 ESTABLISHED INVESTIGATOR AWARD, YOUNG INVESTIGATOR AWARD MEMORIAL SLOAN KETERING CANCER CENTER 1275 YORK AVENUE NEW YORK NY 100656007 131924236 501 (C) (3) 554997 ESTABLISHED INVESTIGATOR AWARDS UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER 1515 HOLCOMBE BOULEVARD HOUSTON TX 770307009 746001118 PUBLIC UNIVERSITY 399999 YOUNG INVESTIGATOR AWARDS, PILOT AWARD THE ROCKEFELLER UNIVERSITY 1230 YORK AVENUE NEW YORK NY 10065 131624158 501 (C) (3) 375000 ESTABLISHED INVESTIGATOR AWARD CHILDREN'S HOSPITAL BOSTON 300 LONGWOOD AVENUE BOSTON MA 02115 042774441 501 (C) (3) 375000 ESTABLISHED INVESTIGATOR AWARD MASSACHUSETTS GENERAL HOSPITAL 55 FRUIT STREET BOSTON MA 02114 042697983 501 (C) (3) 375000 ESTABLISHED INVESTIGATOR AWARD UNIVERSITY OF SOUTHERN CALIFORNIA UNIVERSITY GARDENS SUITE 205 LOS ANGELES CA 900898006 951642394 501 (C) (3) 375000 ESTABLISHED INVESTIGATOR AWARD UNIVERSITY OF HOUSTON 5000 GULF FWY ROOM 109 HOUSTON TX 772040907 746001399 PUBLIC UNIVERSITY 375000 ESTABLISHED INVESTIGATOR AWARD THE REGENTS OF UCSF 1855 FOLSOM STREET BOX 0812 SAN FRANCISCO CA 94143 946036493 PUBLIC UNIVERSITY 375000 ESTABLISHED INVESTIGATOR AWARD THE WISTAR INSTITUTE 3601 SPRUCE STREET PHILADELPHIA PA 19104 236434390 501 (C) (3) 225000 YOUNG INVESTIGATOR AWARD VANDERBILT UNIVERSITY 2301 VANDERBILT PLACE NASHVILLE TN 372406310 620476822 501 (C) (3) 225000 YOUNG INVESTIGATOR AWARD H LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE 12902 MAGNOLIA DRIVE TAMPA FL 33612 592451713 501 (C) (3) 225000 YOUNG INVESTIGATOR AWARD ALBERT EINSTEIN COLLEGE OF MEDICINE 111 EAST 210TH STREET BRONX NY 10467 472209056 501 (C) (3) 100000 PILOT AWARD THE MEDICAL COLLEGE OF WISCONSIN 8701 WATERTOWN PLANK ROAD MILWAUKEE WI 53226 390806261 501 (C) (3) 100000 PILOT AWARD DUKE UNIVESITY 2200 WEST MAIN STREET SUITE 820 DURHAM NC 27705 560532129 501 (C) (3) 100000 PILOT AWARD THE REGENTS OF UCI 141 INNOVATION SUITE 250 IRVINE CA 926977600 952226406 PUBLIC UNIVERSITY 75000 YOUNG INVESTIGATOR AWARD NORTHWESTERN UNIVERSITY 750 NORTH LAKE SHORE DRIVE 7TH FL CHICAGO IL 60611 362167817 501 (C) (3) 60185 TEAM SCIENCE AWARD 20 PART I, LINE 2: EACH PROPOSAL TO THE MRA IS REVIEWED FOR SCIENTIFIC MERIT AND TRANSLATIONAL AND CLINICAL IMPACT BY MRA'S WORLD-CLASS GRANT REVIEW COMMITTEE (GRC). CRITERIA ARE DESCRIBED IN THE MRA'S REQUEST FOR PROPOSALS. GRC MEMBERS ARE SENIOR THOUGHT-LEADERS IN MELANOMA AND CANCER RESEARCH. AFTER SCIENTIFIC PEER REVIEW BY THE GRC, THE MRA BOARD OF DIRECTORS APPROVES FINAL RESEARCH AWARDS FOR FUNDING. RESEARCH AWARD FUNDS ARE DISPENSED ON AN ANNUAL BASIS, CONTINGENT UPON MRA STAFF REVIEW OF ANNUAL PROGRESS REPORTS SUBMITTED BY THE GRANTEES. ALL MRA-FUNDED INVESTIGATORS AND THEIR INSTITUTIONS MUST AGREE TO PERFORM THE RESEARCH PROPOSAL IN FULL COMPLIANCE WITH ALL APPLICABLE LAWS AND REGULATIONS, THE TERMS AND CONDITIONS OF THE MRA REQUEST FOR PROPOSALS, THE REQUIREMENTS OF THE MRA TERMS AND CONDITIONS OF THE RESEARCH PROPOSAL. AT ANY TIME DURING THE AWARD PERIOD, AWARDEES MUST NOTIFY AND MRA MUST APPROVE ANY SIGNIFICANT CHANGES TO THE RESEARCH PROPOSAL INCLUDING RESEARCH PLAN, BUDGET, AND PERSONNEL. AWARDEES PROVIDE MRA WITH ANNUAL WRITTEN REPORTS OF THEIR RESEARCH PROGRESS AND COMPLIANCE WITH BUDGET GUIDELINES. FUNDS ARE DISTRIBUTED IN ANNUAL INSTALLMENTS AND NEXT YEAR'S INSTALLMENT IS NOT PROVIDED UNTIL SATISFACTORY REVIEW BY THE MRA CHIEF SCIENCE OFFICER AND SCIENTIFIC PROGRAM DIRECTOR. AWARDEES MUST KEEP SYSTEMATIC AND COMPLETE RECORDS ON THE RECEIPT AND DISBURSEMENT OF ALL AWARD FUNDS, AND MAY NOT CO-MINGLE ANY FUNDS FROM OTHER SOURCES. X X X 0 0 0 0 0 0 0 1 0 MARGARET ANDERSON DIRECTOR/SECRETARY (LEFT MID-2017) 0 175117 0 60000 0 0 0 7950 0 8445 0 251512 0 0 MICHAEL KLOWDEN DIRECTOR 0 497791 0 125000 0 0 0 7950 0 24396 0 655137 0 0 MICHAEL KAPLAN PRESIDENT & CEO 301504 0 0 0 0 0 4506 0 11622 0 317632 0 0 0 KAMYAB HASHEMI-NEJAD TREASURER 0 177047 0 10000 0 0 0 5744 0 19539 0 212330 0 0 LOUISE PERKINS CHIEF SCIENCE OFFICER 277163 0 15000 0 0 0 7950 0 21951 0 322064 0 0 0 PART I, LINE 7 EMPLOYEES WERE ELIGIBLE TO RECEIVE PERFORMANCE-BASED BONUSES. X 6 422085 FAIR MARKET VALUE X GIFT BAGS PRODUCTS FOR EVENTS 2 92317 FAIR MARKET VALUE X FOOD AND DRINK FOR RECEPTION 1 5603 FAIR MARKET VALUE 0 1 0 PART I, COLUMN (B): NONCASH DONATIONS ARE LISTED BY TOTAL NUMBER OF DONORS. FORM 990, PART V, LINE 2A THE ORGANIZATION DOES NOT ISSUE ANY W-2S FOR THEIR EMPLOYEES. THE SUPPORTED ORGANIZATION, THE MILKEN INSTITUTE, ISSUES ALL W-2S BUT EMPLOYEE COMPENSATION IS PAID BY THE MELANOMA RESEARCH ALLIANCE ITSELF. W-2S REPORTED ARE THOSE THAT ARE ISSUED BY MILKEN INSTITUTE ON BEHALF OF MRA. FORM 990, PART VI, SECTION A, LINE 2 DEBRA BLACK, LEON BLACK AND BEN BLACK HAVE A FAMILY RELATIONSHIP. DEBRA BLACK AND RICHARD RESSLER HAVE A FAMILY RELATIONSHIP. JAMI GERTZ AND DEBRA BLACK HAVE A FAMILY RELATIONSHIP. FORM 990, PART VI, SECTION A, LINE 8B THERE IS NO EXECUTIVE COMMITTEE DURING THE YEAR. FORM 990, PART VI, SECTION B, LINE 11B MRA'S CEO AND TREASURER JOINTLY REVIEW THE FORM 990. THE FINAL DRAFT IS MADE AVAILABLE ELECTRONICALLY TO ALL THE BOARD MEMBERS BEFORE THE CEO SIGNS THE DOCUMENT AND IT IS FILED WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C AS STATED IN THE MRA BYLAWS, EACH DIRECTOR, TRUSTEE, PRINCIPAL OFFICER, AND MEMBER OF A COMMITTEE OF THE BOARD IS TO SIGN A STATEMENT ANNUALLY AFFIRMING THEY HAVE RECEIVED THE CONFLICT OF INTEREST POLICY, THEY HAVE READ AND UNDERSTAND IT, AND THEY AGREE TO COMPLY WITH IT. UPON POTENTIAL CONFLICT OF INTERESTS, THE BOARD OR COMMITTEE WILL RESOLVE THE CONFLICT IN THE BEST INTEREST OF THE ORGANIZATION. FORM 990, PART VI, SECTION B, LINE 15A ACCORDING TO THE MRA BYLAWS, MEMBERS OF THE BOARD REVIEW AND APPROVE THE MRA CEO SALARY TO ENSURE IT IS JUST AND REASONABLE. DURING THIS ANNUAL REVIEW, MEMBERS OF THE BOARD USE THE FEDERAL FORM 990 OF OTHER ORGANIZATIONS FOR COMPARABLES. THERE ARE NO OTHER OFFICERS, DIRECTORS, OR KEY EMPLOYEES THAT ARE COMPENSATED BY MRA. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. A COPY OF THE FORM 990 AND THE FINANCIAL STATEMENTS ARE AVAILABLE ON THE ORGANIZATION'S WEBSITE. FORM 990, PART XI, LINE 9: LOSS ON WRITE-OFF OF UNCOLLECTIBLE PLEDGES RECEIVABLE -100,000. DISCOUNT ON GRANTS TO OTHER ORGANIZATION 137,515. GRANT FUNDS RETURNED -55,939. MILKEN INSTITUTE 1250 FOURTH STREET SANTA MONICA CA 90401 954240775 EDUCATIONAL, ECONOMIC RESEARCH, HEALTHCARE RESEARCH CA 501(C)(3) LINE 7 N/A 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0